Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma

Figure 4

Risk score of HCC patients in the TCGA test cohort. (a) The Kaplan–Meier survival analysis of HCC patients. (b) ROC curve for the risk score and clinicopathological characteristics of HCC patients. (c) Heatmap of the expression pattern of the seven-MRM signature for the high-risk and low-risk groups. (d) Risk score distribution in each HCC patient. (e) The OS and OS status for the high-risk and low-risk groups.

(a)

(b)

(c)

(d)

(e)